Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia
- 1 March 1995
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 14 (3) , 182-187
- https://doi.org/10.1007/bf02310353
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. The British Thoracic Society.1993
- Deaths in Bacteremic Pneumococcal PneumoniaChest, 1993
- AzithromycinDrugs, 1992
- Infections Caused by Streptococcus pneumoniae: Clinical Spectrum, Pathogenesis, Immunity, and TreatmentClinical Infectious Diseases, 1992
- Pneumococcal bacteraemia during a recent decadeJournal of Infection, 1992
- CD4+ Cells and CD4 + Percent as Risk Markers for Pneumocystis carinii Pneumonia (PCP): Implications for Primary PCP ProphylaxisScandinavian Journal of Infectious Diseases, 1992
- The future role and importance of macrolidesJournal of Hospital Infection, 1991
- New and Emerging Etiologies for Community-Acquired Pneumonia with Implications for TherapyMedicine, 1990
- Community-acquired pneumoniaRespiratory Medicine, 1987
- Epidemiology of community-acquired respiratory tract infections in adults: Incidence, etiology, and impactThe American Journal of Medicine, 1985